Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6

Since tectorigenin has been reported to possess anti-inflammation, redox balance restoration, and anti-apoptosis properties, we determine to unravel whether tectorigenin has potential in alleviating spinal cord injury (SCI). Herein, PC12 cells were induced by lipopolysaccharide (LPS) to establish in...

Full description

Bibliographic Details
Main Authors: Zhou Liqiang, Yan Kui, Xing Shuxing, Cheng Jun
Format: Article
Language:English
Published: De Gruyter 2023-04-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2023-0680
_version_ 1797832502934503424
author Zhou Liqiang
Yan Kui
Xing Shuxing
Cheng Jun
author_facet Zhou Liqiang
Yan Kui
Xing Shuxing
Cheng Jun
author_sort Zhou Liqiang
collection DOAJ
description Since tectorigenin has been reported to possess anti-inflammation, redox balance restoration, and anti-apoptosis properties, we determine to unravel whether tectorigenin has potential in alleviating spinal cord injury (SCI). Herein, PC12 cells were induced by lipopolysaccharide (LPS) to establish in vitro SCI models. The cell viability and apoptosis were detected through cell counting kit-8 and flow cytometry assays. The caspase-3/8/9 content was measured by colorimetric method. Western blot was conducted to quantify the expressions of cleaved caspse-3/8/9, IGFBP6, TLR4, IκBα, p-IκBα, RELA proto-oncogene, p65, and p-p65. Enzyme-linked immunosorbent assay and real-time quantitative polymerase chain reaction were carried out to quantitate expressions of IGFBP6, interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). SwissTargetPrediction and GSE21497 database were utilized to predict the potential therapeutic targets of tectorigenin. Comparison of IGFBP6 expression in SCI tissues and normal tissues was analyzed by GEO2R. Our study found that LPS induced the declined cell viability, elevated cell apoptosis, upregulation of caspase-3/8/9, cleaved caspase-3/8/9, IL-1β, IL-6, TNF-α, IGFBP6, and TLR4, and the activation of IκBα and p65 in PC12 cells. Tectorigenin reversed the above effects of LPS. IGFBP6 was predicted to be the potential therapeutic target of tectorigenin and was overexpressed in SCI tissues. Notably, IGFBP6 overexpression offset the effects of tectorigenin on PC12 cells. In conclusion, tectorigenin could alleviate the LPS-induced apoptosis, inflammation, and activation of NF-κB signaling in SCI cell models via inhibiting IGFBP6.
first_indexed 2024-04-09T14:10:00Z
format Article
id doaj.art-8db2b758c633431b8c864619dfc27554
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-04-09T14:10:00Z
publishDate 2023-04-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-8db2b758c633431b8c864619dfc275542023-05-06T15:31:53ZengDe GruyterOpen Medicine2391-54632023-04-01181355610.1515/med-2023-0680Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6Zhou Liqiang0Yan Kui1Xing Shuxing2Cheng Jun3Department of Orthopedics, Chengdu Fifth People’s Hospital, Chengdu, Sichuan Province, 611130, ChinaDepartment of Orthopedics, Chengdu Fifth People’s Hospital, Chengdu, Sichuan Province, 611130, ChinaDepartment of Orthopedics, Chengdu Fifth People’s Hospital, No. 33 Mashi Street, Wenjiang District, Chengdu, Sichuan Province, 611130, ChinaDepartment of Orthopedics, Chengdu Fifth People’s Hospital, Chengdu, Sichuan Province, 611130, ChinaSince tectorigenin has been reported to possess anti-inflammation, redox balance restoration, and anti-apoptosis properties, we determine to unravel whether tectorigenin has potential in alleviating spinal cord injury (SCI). Herein, PC12 cells were induced by lipopolysaccharide (LPS) to establish in vitro SCI models. The cell viability and apoptosis were detected through cell counting kit-8 and flow cytometry assays. The caspase-3/8/9 content was measured by colorimetric method. Western blot was conducted to quantify the expressions of cleaved caspse-3/8/9, IGFBP6, TLR4, IκBα, p-IκBα, RELA proto-oncogene, p65, and p-p65. Enzyme-linked immunosorbent assay and real-time quantitative polymerase chain reaction were carried out to quantitate expressions of IGFBP6, interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). SwissTargetPrediction and GSE21497 database were utilized to predict the potential therapeutic targets of tectorigenin. Comparison of IGFBP6 expression in SCI tissues and normal tissues was analyzed by GEO2R. Our study found that LPS induced the declined cell viability, elevated cell apoptosis, upregulation of caspase-3/8/9, cleaved caspase-3/8/9, IL-1β, IL-6, TNF-α, IGFBP6, and TLR4, and the activation of IκBα and p65 in PC12 cells. Tectorigenin reversed the above effects of LPS. IGFBP6 was predicted to be the potential therapeutic target of tectorigenin and was overexpressed in SCI tissues. Notably, IGFBP6 overexpression offset the effects of tectorigenin on PC12 cells. In conclusion, tectorigenin could alleviate the LPS-induced apoptosis, inflammation, and activation of NF-κB signaling in SCI cell models via inhibiting IGFBP6.https://doi.org/10.1515/med-2023-0680spinal cord injurypc12lpstectorigeninigfbp6
spellingShingle Zhou Liqiang
Yan Kui
Xing Shuxing
Cheng Jun
Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
Open Medicine
spinal cord injury
pc12
lps
tectorigenin
igfbp6
title Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
title_full Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
title_fullStr Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
title_full_unstemmed Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
title_short Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
title_sort tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin like growth factor binding protein 6
topic spinal cord injury
pc12
lps
tectorigenin
igfbp6
url https://doi.org/10.1515/med-2023-0680
work_keys_str_mv AT zhouliqiang tectorigeninalleviatestheapoptosisandinflammationinspinalcordinjurycellmodelthroughinhibitinginsulinlikegrowthfactorbindingprotein6
AT yankui tectorigeninalleviatestheapoptosisandinflammationinspinalcordinjurycellmodelthroughinhibitinginsulinlikegrowthfactorbindingprotein6
AT xingshuxing tectorigeninalleviatestheapoptosisandinflammationinspinalcordinjurycellmodelthroughinhibitinginsulinlikegrowthfactorbindingprotein6
AT chengjun tectorigeninalleviatestheapoptosisandinflammationinspinalcordinjurycellmodelthroughinhibitinginsulinlikegrowthfactorbindingprotein6